Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 931 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Medunik Canada to market new therapies for rare diseases

Sucraid oral solution is an enzyme replacement therapy (ERT) for genetically determined sucrase deficiency, which is part of a rare, chronic disease, congenital sucrase-isomaltase deficiency (CSID). Ethamolin (Ethanolamine

USPTO grants patent to Antares Pharma LibiGel

The patent covers a specially designed transdermal or transmucosal formulation to treat hypoactive sexual desire disorder (HSDD) or female sexual dysfunction (FSD). The method may also be used

FDA approves Watson Vestura ANDA

Watson’s Vestura is generic equivalent to Bayer’s Yaz oral contraceptive product. Watson’s Vestura is an oral contraceptive used to prevent pregnancy and treat moderate acne in women. The

NAI secures new US patent for beta-alanine

The patent contains claims regarding beta-alanine compositions in many formulations, wherein the beta-alanine is not part of a dipeptide, polypeptide or oligopeptide and is in the form of

Cuba to combat cancer with new biotechnological branch

Researchers from Cuba intend to step-up the national production of antineoplastic and complementary drugs, besides making biotechnological products, cubanews.ain.cu reported citing cubadebate.cu. It is estimated that following the

Leonardo, NMA ink deal for production of nanoparticles

Leonardo technology comprises fully biodegradable, porous silicon particles that can be loaded with a diverse array of secondary nanoparticles such as liposomes, micelles, carbon nanotubes, dendrimers and metallic